Heron Therapeutics | HRTX - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
ALKERMES USD 8.54M 3.59M 2026-03
Alnylam Pharmaceuticals USD 26.63M 2.05M 2025-12
Amarin USD 3.37M 3.37M 2024-12
Arrowhead Research USD 9.69M 637K 2025-12
Eisai JPY 3.11B 783M 2024-03
Esperion Therapeutics USD -0.15 0.18 2024-09
GlaxoSmithKline GBP 22M 96M 2026-03
Heron Therapeutics USD 433K 277K 2021-12
Insmed USD 765K 55K 2024-09
Ligand Pharmaceuticals USD 6.39M 2.52M 2025-12
Merck USD 69M 27M 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Pacira USD 2.3M 6.24M 2025-12
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Ultragenyx Pharmaceutical USD 6.51M 649K 2025-12
Veracyte USD 3.48M 545K 2025-09
Vertex Pharmaceuticals USD 114.8M 7.1M 2026-03